Results 291 to 300 of about 5,734,618 (390)

A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS). [PDF]

BMC Pharmacol Toxicol
Xiong X, Zhang X, Tang F, Huang T.
europepmc   +1 more source

Efficient and Scalable Radiative Cooling for Photovoltaics Using Solution‐Processable and Solar‐Transparent Mesoporous Nanoparticles

Advanced Functional Materials, EarlyView.
Graded refractive index (GRI) structures are prepared from the layer‐by‐layer spray coating of the mesoporous SiO2 nanoparticles, showing high solar transparency and thermal emissivity. Under outdoor conditions, after 50 days, the GRI‐coated photovoltaics show on average 6.65 ± 1.48 °C lower than that of the non‐coated references, maintaining 80.9 ± 8 ...
Heesuk Jung, Sung Yoon Min, Byungsoo Kang, Yongseok Yoo, Jihun Jang, Yeoun‐Woo Jang, Hyojeong Choi, Hyeong Won Lee, Swarup Biswas, Yongju Lee, Mansoo Choi, Phillip Lee, Min Seok Jang, Hyeok Kim, Shu Yang   +14 more
wiley   +1 more source

Quality control, audit, adverse events and risk in the intensive care unit

, 2000
L.I.G. Worthley
openalex   +1 more source

Ticlopidine Pretreatment Before Coronary Stenting Is Associated With Sustained Decrease in Adverse Cardiac Events [PDF]

, 2001
Steven R. Steinhubl, Stephen G. Ellis, Kathy Wolski, A. Michael Lincoff, Eric J. Topol   +4 more
openalex   +1 more source

Adverse event profile of lomustine and temozolomide: a descriptive analysis from WHO-VigiAccess. [PDF]

Front Pharmacol
Luo H, Fan S, Liang L, He Y, Chen J, Xu C, Zhu J, Zhang L.   +7 more
europepmc   +1 more source

Extracorporeal Catalytic Hemoperfusion Therapy for Refractory Septic Shock Using Ceria Nanoparticle‐Embedded Porous Microbeads

Advanced Functional Materials, EarlyView.
This study introduces an extracorporeal hemoperfusion system incorporating porous microbeads embedded with autocatalytic ceria nanoparticles (CeNPs) for targeted reactive oxygen species (ROS) scavenging in septic shock. The blood‐compatible hemoperfusion cartridge demonstrated significant improvements in survival, hemodynamic stability, and organ ...
Pilseon Im, Han‐Gil Jeong, Donghee Kim, Jimin Song, Ngoc Man Phan, Eun‐seo Choi, Young‐Min Kim, Seo‐Hyeon Jeong, Jooho Park, Inwon Park, Jaeyun Kim   +10 more
wiley   +1 more source

Identifying hospital admissions due to adverse drug events using a computer‐based monitor [PDF]

, 2001
Ashish K. Jha, Gilad J. Kuperman, Eve Rittenberg, Jonathan M. Teich, David W. Bates   +4 more
openalex   +1 more source

Oseltamivir-induced hepatotoxicity: A retrospective analysis of the FDA adverse event reporting system. [PDF]

PLoS One
Yu L, Xiang Q, Liu L.
europepmc   +1 more source

Joule‐Assisted Nanotherapeutic Urethral Stent (JANUS) for Spatiotemporal Theragenerative Treatment of Urethral Strictures

Advanced Functional Materials, EarlyView.
Joule‐assisted nanotherapeutic urethral stent harnesses a smart, biodegradable magnesium stent to orchestrate spatiotemporal theragenerative therapy for urethral strictures. Magnetically induced Joule heating enables on‐demand drug release and bacterial ablation, while simultaneously guiding urothelial regeneration.
Yuhyun Na, Yubeen Park, Hyun Lee, Song Hee Kim, Seojoon Bang, Hyeong Seok Kang, Chan Ho Moon, Ju Yeong Gwon, Jong Hwa Seo, Min‐Ho Kang, Soo‐Hong Lee, Gi Doo Cha, Wooram Park, Heemin Kang, Jung‐Hoon Park, Hyun‐Do Jung   +15 more
wiley   +1 more source

Potential risks and prevention, part 1: Fatal adverse drug events [PDF]

, 2001
William N. Kelly
openalex   +1 more source